Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:dateCreated |
1980-9-28
|
| pubmed:abstractText |
Cefaclor, a new semisynthetic cephalosporin antibiotic for oral use, was studied by 62 clinical investigators in 6 countries in 1493 adult and paediatric patients. The pooled data reveal that satisfactory clinical responses were obtained in 80% of urinary tract infections, 87% of upper respiratory infections, 90% of cases of otitis media, 99% of lower respiratory tract infections, and 96% of skin and skin structure infections. Administration of this antibiotic was associated with a low incidence of adverse reactions including gastrointestinal (2.6%) and hypersensitivity reactions (1.5%). Of particular clinical interest were the outstanding results obtained in the treatment of otitis media and lower respiratory tract infections.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0032-5473
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
55 Suppl 4
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
93-9
|
| pubmed:dateRevised |
2009-10-22
|
| pubmed:meshHeading |
pubmed-meshheading:548945-Adult,
pubmed-meshheading:548945-Bacteria,
pubmed-meshheading:548945-Bacterial Infections,
pubmed-meshheading:548945-Cefaclor,
pubmed-meshheading:548945-Cephalexin,
pubmed-meshheading:548945-Child,
pubmed-meshheading:548945-Humans,
pubmed-meshheading:548945-Otitis Media,
pubmed-meshheading:548945-Pharyngitis,
pubmed-meshheading:548945-Respiratory Tract Infections,
pubmed-meshheading:548945-Skin Diseases, Infectious,
pubmed-meshheading:548945-Streptococcal Infections,
pubmed-meshheading:548945-Urinary Tract Infections
|
| pubmed:year |
1979
|
| pubmed:articleTitle |
Cefaclor--summary of clinical experience.
|
| pubmed:publicationType |
Journal Article
|